From DIY security systems to a professionally installed home kit, buyers have to make an important choice: Pay extra for professional monitoring or save with self-monitoring. With a professional ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

BOSTON — To say that Jimmy Magnasco goes all out to celebrate Halloween is an understatement. Every year, the East Boston resident has hundreds of people flock to his East Boston neighborhood, where ...

Another key trend in the market is the rise in wireless pacemakers. St. Jude Medical launched the Entovis pacemaker in 2013. This pacemaker can communicate wirelessly with an external monitoring ...

The droplet battery can deliver defibrillator electric shocks to beating mouse hearts, along with providing pacemaker-style control – but it may eventually power biomedical implants and wearable ...

Testing: The pacemaker is tested to ensure it works properly and the electrical signals are effectively regulating the heartbeat. Closure: The incision is closed with stitches, and a dressing is ...

Boston Scientific Corporation (NYSE ... which received FDA approval in the quarter and our EMPOWUR leadless pacemaker, which ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

BOSTON – The Bruins will be back on home ice on Thursday night when they host the Dallas Stars at TD Garden. Boston will be aiming to snap its two-game skid after dropping the final two contests ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...